A.3 A novel recessive TNNT1 congenital core-rod myopathy in French Canadians

نویسندگان

چکیده

Background: Mutations in the slow skeletal muscle troponin T ( TNNT1 ) gene cause a congenital nemaline myopathy resulting death from respiratory insufficiency early infancy. We report on four French Canadians with novel myopathy. Methods: Patients underwent lower extremity and paraspinal MRI, quadriceps biopsy genetic testing. expression was assessed by quantitative PCR immunoblotting. Wild type or mutated mRNAs were co-injected morpholinos zebrafish knockdown model to assess for rescue of morphant phenotype. Results: Four patients shared missense homozygous mutation . They developed childhood slowly progressive limb-girdle weakness spinal rigidity contractures. suffered restrictive lung disease recurrent episodes rhabdomyolysis. Older remained ambulatory into their sixties. Lower MRI showed symmetrical myopathic changes. Paraspinal diffuse fibro-fatty involution. Biopsies multi-minicores. Nemaline rods seen half patients. mRNA similar controls patients, while levels protein reduced rescued morphants but mutant transcripts failed do so. Conclusions: This study expands spectrum -related include milder clinical phenotype caused functionally-confirmed mutation.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Novel autosomal dominant TNNT1 mutation causing nemaline myopathy

BACKGROUND Nemaline myopathy (NEM) is one of the three major forms of congenital myopathy and is characterized by diffuse muscle weakness, hypotonia, respiratory insufficiency, and the presence of nemaline rod structures on muscle biopsy. Mutations in troponin T1 (TNNT1) is 1 of 10 genes known to cause NEM. To date, only homozygous nonsense mutations or compound heterozygous truncating or inter...

متن کامل

A Novel Missense Mutation in CLCN1 Gene in a Family with Autosomal Recessive Congenital Myotonia

Congenital recessive myotonia is a rare genetic disorder caused by mutations in CLCN1, which codes for the main skeletal muscle chloride channel ClC-1. More than 120 mutations have been found in this gene. The main feature of this disorder is muscle membrane hyperexcitability. Here, we report a 59-year male patient suffering from congenital myotonia. He had transient generalized myotonia, which...

متن کامل

Nemaline body myopathy caused by a novel mutation in troponin T1 (TNNT1).

INTRODUCTION Nemaline myopathy is a rare disorder characterized by skeletal muscle weakness of varying severity and onset, with the presence of nemaline rods on muscle biopsy. Congenital nemaline body myopathy due to mutations in TNNT1 has hitherto only been described as a result of a single founder mutation in patients of Amish origin and in 2 other individuals with different recessive mutatio...

متن کامل

Autosomal recessive distal myopathy.

Five patients with an autosomally recessively transmitted distal myopathy were investigated. Of these, three belonged to a single sibship. Studies included electromyography, histological examination of muscle tissue, histochemical, electron microscopical, and biochemical analyses. One of the cases resembled the Nonaka form while the others were regarded as expressions of the commoner variety of...

متن کامل

Nemaline rod myopathy: a rare form of myopathy.

Nemaline rod myopathy (NM) is a rare form of congenital myopathy characterized by slowly progressive or nonprogressive muscle weakness and pathognomonic rod-like structures within the muscle fibers. To the best of our knowledge, this is first documentation of the clinicopathological features of this rare entity from India. All cases of NM diagnosed in our laboratory were retrieved. Clinical and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Canadian Journal of Neurological Sciences

سال: 2022

ISSN: ['2057-0155', '0317-1671']

DOI: https://doi.org/10.1017/cjn.2022.93